Article PDF
Avoid common mistakes on your manuscript.
References
Spiteri G, Fielding J, Diercke M, et al. First cases of Coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Euro Surveill 2020; 25: 9.
Englund J, Feuchtinger T, Ljungman P. Viral infections in immunocompromised patients. Biol Blood Marrow Transplant 2011; 17: S2–5.
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054–62.
D’Antiga L. Coronaviruses and immunosuppressed patients. The facts during the third epidemic. Liver Transpl 2020; 26: 832–4.
Zhu L, Xu X, Ma K, et al. Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression. Am J Transplant 2020; 20: 1859–63.
Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokinestorm syndromesand immunosuppression. Lancet 2020; 395: 1033–4.
Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020; 21: 335–7.
Hodi FS, Chiarion-Sileni V, Gonzalez R, et al. Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial. Lancet Oncol 2018; 19: 1480–92.
Migden MR, Khushalani NI, Chang ALS, et al. Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial. Lancet Oncol 2020; 21: 294–305.
Author information
Authors and Affiliations
Corresponding author
Additional information
Disclosures
Funding sources: none. Conflicts of interest: none.
About this article
Cite this article
Reinholz, M., French, L.E., Berking, C. et al. The COVID-19 pandemic: implications for patients undergoing immunomodulating or immunosuppressive treatments in dermatology. Eur J Dermatol 30, 757–758 (2020). https://doi.org/10.1684/ejd.2020.3775
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2020.3775